In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study (Q43089537)
Jump to navigation
Jump to search
scientific article published in July 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study |
scientific article published in July 2010 |
Statements
1 reference
In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study (English)
1 reference
1 reference
1 reference
1 reference
Richard B Devereux
1 reference
Kristian Wachtell
1 reference
Eva Gerdts
1 reference
Michael H Olsen
1 reference
Markku S Nieminen
1 reference
Gerard P Aurigemma
1 reference
Jens E Rokkedal
1 reference
1 July 2010
1 reference
1 reference
28
1 reference
7
1 reference
1541-1546
1 reference
Identifiers
1 reference
1 reference